Speakers & Scientific Chairs: Bios in Brief
Speakers and scientific chairs bring the program to life. They are selected not only for their expertise but also for their ability to create dialogue, spark curiosity, and connect science with society. Selection emphasizes diversity of disciplines, regions, career stages, and perspectives. This breadth ensures that participants encounter voices from research, clinical practice, regulation, and industry—each contributing to the collective conversation.
What Our Chairs Do
Scientific chairs play a central role in shaping the program. Their responsibilities extend beyond introducing speakers; they are the curators of conversation and the guardians of quality.
- Curate: Chairs work with organizers to shape session content, selecting speakers who represent a range of expertise and perspectives. They ensure sessions are relevant, balanced, and aligned with the program’s Program Overview.
- Moderate: During live sessions, chairs guide discussion, keep time, and facilitate Q&A. They help create an environment where diverse voices are heard and discussions remain focused.
- Synthesize: At the end of sessions, chairs often highlight key themes, clarify points of agreement or debate, and link the discussion back to broader program goals. This synthesis helps participants connect what they’ve heard to their own work.
Chairs are thus both leaders and facilitators—ensuring that sessions are not only informative but also interactive and impactful.
Speaker Spotlights
Below are brief sketches of selected speakers, illustrating the range of expertise represented. These bios are concise by design, highlighting roles, focus areas, and contributions without lengthy resumes.
Dr. Amina Reyes — Translational Immunologist
Dr. Reyes is a clinician–scientist focused on immune cell therapies for hematologic cancers. Her work integrates laboratory discovery with early-phase trials, ensuring patients benefit quickly from new approaches. She is passionate about mentoring young investigators and advancing equitable access to experimental treatments.
Prof. Mark Chen — Manufacturing Innovator
Prof. Chen specializes in bioprocess engineering and analytics. His group develops scalable systems for cell and gene therapy production. He has partnered with regulators and industry to establish quality standards that accelerate safe adoption. Prof. Chen is known for translating complex engineering advances into practical frameworks for global manufacturing.
Dr. Sofia Alvarez — Gene Editing Pioneer
Dr. Alvarez studies precision gene editing for inherited metabolic diseases. Her work emphasizes delivery mechanisms and long-term monitoring strategies. She collaborates widely across academia and industry, balancing technical innovation with community engagement. She is an advocate for transparent communication of risks and benefits.
Dr. Daniel Mensah — Regulatory Scientist
Dr. Mensah serves in a national regulatory authority and is known for his expertise in harmonizing international guidelines. He bridges the gap between scientific advances and public policy, ensuring that innovation aligns with safety, efficacy, and transparency. His approach emphasizes dialogue between regulators, clinicians, and developers.
Prof. Leila Gupta — Bioethics & Access Advocate
Prof. Gupta’s scholarship addresses the ethical, social, and global dimensions of advanced therapies. She works with community groups and global health organizations to design frameworks for equitable access. Her voice ensures that scientific discussions remain grounded in fairness, responsibility, and inclusion.
Dr. Tomas Eriksen — Clinical Trialist
Dr. Eriksen leads multi-center trials exploring novel gene therapies for neuromuscular conditions. His expertise lies in designing adaptive protocols and incorporating patient-reported outcomes. He collaborates closely with patient advocacy groups, highlighting the importance of trust in trial participation.
Dr. Maya Kline — Digital Analytics Specialist
Dr. Kline focuses on data-driven approaches to monitoring therapy performance. Her research applies machine learning to manufacturing analytics, creating real-time quality dashboards. She contributes to the program by linking advanced data science with practical manufacturing outcomes.
Prof. Hassan Al-Mutairi — Educator & Mentor
Prof. Al-Mutairi is recognized for developing training programs that prepare the next generation of scientists and clinicians. His work emphasizes interdisciplinary education, ethics, and professional development. He often chairs sessions designed for early-career participants.
Dr. Carla Jiménez — Industry Strategist
Dr. Jiménez leads innovation strategy in a biopharmaceutical company, aligning R&D priorities with emerging science. She brings a perspective on how industry can partner with academia and regulators to accelerate therapeutic pipelines. Her focus includes workforce development and sustainability in biotech.
Dr. Noah Stein — Poster Theatre Champion
Dr. Stein is an early-career researcher presenting exploratory data on novel delivery methods. As both speaker and listener, he embodies the spirit of the poster hall: sharing work openly, inviting critique, and contributing to a community of learning.
These spotlights illustrate how speakers complement one another: pioneers and early-career scientists, regulators and industry leaders, ethicists and clinicians—all engaging under one program. For details on roles and session types, see Session Formats.
Disclosures & Integrity
Transparency is essential to maintaining trust. All speakers and chairs are asked to disclose potential conflicts of interest in plain language. This includes relationships with companies, financial interests, or roles that could influence interpretation of data.
Disclosures are provided at the beginning of sessions so participants can interpret presentations with full context. Integrity means:
- Presenting data accurately, without selective omission.
- Distinguishing between evidence and opinion.
- Acknowledging limitations as well as successes.
- Respecting patient privacy and never sharing identifiable health information.
These principles ensure that sessions remain constructive, credible, and respectful. Integrity is not an afterthought—it is a foundation for learning.
How to Connect During Q&A
Q&A is one of the best opportunities to engage directly with speakers and chairs. To make these exchanges productive, keep the following guidance in mind:
Be Clear and Concise
Ask your question directly in a sentence or two. Clarity helps speakers provide focused answers.
Relate to the Session
Frame your question around points already discussed. This shows engagement and keeps dialogue relevant.
Respectful Tone
Approach Q&A as a conversation, not a debate. Critical questions are welcome, but they should be posed respectfully.
Evidence Sharing
If you mention other work, summarize findings in plain English. Avoid long citations—focus on the insight most relevant to the session.
Time Awareness
Allow space for others. If your question requires a deeper exchange, follow up after the session through Networking & Partnering.
Use Moderators
Chairs moderate Q&A to ensure balance. Follow their instructions for turn-taking or submitting written questions.
By following these guidelines, participants help create a culture of dialogue where every voice contributes constructively.
Closing
Speakers and scientific chairs are the lifeblood of the program. Their expertise, diversity, and commitment to integrity make the sessions more than presentations—they become conversations that shape the future of science, medicine, and policy. By understanding the roles of chairs, appreciating the breadth of speaker spotlights, respecting disclosures, and engaging thoughtfully during Q&A, participants can fully benefit from the program’s collective wisdom.
For additional context, see the Program Overview, explore Session Formats, connect via Networking & Partnering, or reach us through Contact.